Science, technology, and innovation policy timing and nanotechnology entrepreneurship and innovation.

The timing of science, technology, and innovation (STI) policy initiatives is critical to the outcomes that they produce. This study examines the advantages and disadvantages of enacting STI policy investments early in a nascent domain of activity. Building on work across multiple disciplines, we propose a framework to better understand the temporal dynamics of STI policy.

Bridging the gap: engaging researchers and advocates to build support for TB vaccine research and development.

The success of global efforts to develop new TB vaccines will rely on both addressing the scientific challenges identified throughout this Blueprint and mobilizing sufficient support and resources to sustain and advance the TB vaccine pipeline. As outlined in the TB Vaccine Blueprint, activities over the next decade will include expanding financing to provide sufficient resources, raising awareness of the need for new TB vaccines, and broadening the base of advocates, allies and champions for TB vaccine R&D. These activities will only be successful if advocates and researchers - including scientists, clinicians and product developers - work together.